Section Arrow
Quote
BNTX.NASDAQ
- BioNTech SE American Depositary Share
Quotes are at least 15-min delayed:2026/01/08 03:45 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 100.08
+1.99 (+2.03%)
Day High 
101.48 
Prev. Close
98.09 
1-M High
99.56 
Volume 
1.07M 
Bid
--
Ask
--
Day Low
97.795 
Open
98.28 
1-M Low
91.11 
Market Cap 
24.61B 
Currency 美元 
P/E 152.23 
%Yield 2.13 
10-SMA 95.32 
20-SMA 94.72 
50-SMA 99.16 
52-W High 126.77 
52-W Low 81.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.39/-5.18
Enterprise Value
24.83B
Balance Sheet
Book Value Per Share
86.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.75B
Operating Revenue Per Share
27.92
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1256+0.0206+19.62%-- 
Pre Market -- -- --
ERASErasca5.17+1.54+42.42%-- 
Pre Market -- -- --
RXRXRecursion Pharmaceuticals4.86+0.31+6.81%-- 
Pre Market -- -- --
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
Pre Market -- -- --
GLUEMonte Rosa Therapeutics23.28+7.27+45.41%54.09PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed
Business Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine,is its first commercialized product.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.